Takeda M, Ota M, Iwama E, Sugawara S, et al. A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial). Clin Lung Cancer 2024 Dec 9:S1525-7304(24)00267.
PMID: 39743377